2020 MIPS Measure #476: International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia

Measure Type High Priority Measure? Collection Type(s)
Patient Reported Outcome yes eCQM

Measure Description

Percentage of patients with an office visit within the measurement period and with a new diagnosis of clinically significant Benign Prostatic Hyperplasia who have International Prostate Symptoms Score (IPSS) or American Urological Association (AUA) Symptom Index (SI) documented at time of diagnosis and again 6-12 months later with an improvement of 3 points.

Stay up to date with the latest news regarding MACRA and MIPS.

The Healthmonix Advisor is a free weekly news source, connecting you to the latest updates in the value-based care industry.


CMS-Family-Medicine-2020, CMS-Geriatrics-2020, CMS-Infectious-Disease-2020, CMS-Internal-Medicine-2020, CMS-Obstetrics-Gynecology-2020, CMS-Preventive-Medicine-2020, CMS-Urology-2020, Internal Medicine, Obstetrics/Gynecology, Preventive Medicine, Quality-2020